
Most Americans with type 2 diabetes are candidates for newer, pricey medications, but few are getting them, a new government study shows. Researchers found that of U.S. adults with the blood sugar disease, over 80% could stand to benefit from the medications, based on recommendations from the American Diabetes Association (ADA). But only 10% of… read on > read on >